1. Home
  2. ADPT vs PLAB Comparison

ADPT vs PLAB Comparison

Compare ADPT & PLAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ADPT
  • PLAB
  • Stock Information
  • Founded
  • ADPT 2009
  • PLAB 1969
  • Country
  • ADPT United States
  • PLAB United States
  • Employees
  • ADPT N/A
  • PLAB N/A
  • Industry
  • ADPT Biotechnology: Biological Products (No Diagnostic Substances)
  • PLAB Semiconductors
  • Sector
  • ADPT Health Care
  • PLAB Technology
  • Exchange
  • ADPT Nasdaq
  • PLAB Nasdaq
  • Market Cap
  • ADPT 1.1B
  • PLAB 1.3B
  • IPO Year
  • ADPT 2019
  • PLAB 1987
  • Fundamental
  • Price
  • ADPT $9.03
  • PLAB $19.45
  • Analyst Decision
  • ADPT Buy
  • PLAB Strong Buy
  • Analyst Count
  • ADPT 6
  • PLAB 1
  • Target Price
  • ADPT $9.83
  • PLAB $35.00
  • AVG Volume (30 Days)
  • ADPT 3.0M
  • PLAB 608.6K
  • Earning Date
  • ADPT 05-01-2025
  • PLAB 05-21-2025
  • Dividend Yield
  • ADPT N/A
  • PLAB N/A
  • EPS Growth
  • ADPT N/A
  • PLAB 5.99
  • EPS
  • ADPT N/A
  • PLAB 2.35
  • Revenue
  • ADPT $189,527,000.00
  • PLAB $862,750,000.00
  • Revenue This Year
  • ADPT $21.20
  • PLAB $2.60
  • Revenue Next Year
  • ADPT $21.99
  • PLAB $6.56
  • P/E Ratio
  • ADPT N/A
  • PLAB $8.25
  • Revenue Growth
  • ADPT 8.61
  • PLAB N/A
  • 52 Week Low
  • ADPT $2.99
  • PLAB $16.46
  • 52 Week High
  • ADPT $10.28
  • PLAB $31.60
  • Technical
  • Relative Strength Index (RSI)
  • ADPT 57.82
  • PLAB 55.31
  • Support Level
  • ADPT $8.38
  • PLAB $18.59
  • Resistance Level
  • ADPT $9.51
  • PLAB $19.42
  • Average True Range (ATR)
  • ADPT 0.66
  • PLAB 0.47
  • MACD
  • ADPT 0.16
  • PLAB 0.24
  • Stochastic Oscillator
  • ADPT 63.02
  • PLAB 87.12

About ADPT Adaptive Biotechnologies Corporation

Adaptive Biotechnologies Corp is a company advancing the field of immune-driven medicine by harnessing the inherent biology of the adaptive immune system to transform the diagnosis and treatment of disease. Its clinical diagnostic product, clonoSEQ, is test authorized by the FDA for the detection and monitoring of minimal residual disease (MRD) in patients with multiple myeloma (MM), B cell acute lymphoblastic leukemia (ALL) and chronic lymphocytic leukemia (CLL) and is also available as a CLIA-validated laboratory developed test (LDT) for patients with other lymphoid cancers, including diffuse large B-cell lymphoma (DLBCL).

About PLAB Photronics Inc.

Photronics Inc is a U.S.-based company that is principally engaged in manufacturing photomasks. The photomasks are photographic quartz or glass plates that contain microscopic images of electronic circuits that are used as a component in the manufacture of integrated circuits and flat-panel displays. The revenue from products designed for integrated circuits production accounts for the majority of total revenue, with the rest derived from products for flat-panel display production. The company's assets are located in Taiwan, Korea, and the United States. It generates revenue world-wide, including in the United States, Europe, Taiwan, Korea, China, and elsewhere in Asia, with Taiwan contributing the majority of total revenue.

Share on Social Networks: